Literature DB >> 511298

Permeability factor contaminating hyaluronidase preparations.

J C Houck, C M Chang.   

Abstract

Both crude and highly purified testicular hyaluronidase preparations have been shown to contain a component which increases the permeability of the microcirculation in rat skin. This permeability activity had an isoelectric point of 7.4 while hyaluronidase was 9.4. It also could be separated from hyaluronidase by acrylamide gel electrophoresis. The permeability factor was not inhibited by serum and may explain previous observations that hyaluronidase preparations decrease the ischemia and necrosis appropriate to experimental myocardial infarction in vivo.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511298     DOI: 10.1007/bf00913502

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  9 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  The turbidimetric estimation of hyaluronate.

Authors:  R H PEARCE
Journal:  Biochem J       Date:  1953-10       Impact factor: 3.857

3.  The effects of serum and of hyaluronic acid derivatives on the action of hyaluronidase.

Authors:  Z Hadidian; N W Pirie
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

4.  Mucolytic enzyme systems. XVII. Purification of the nonspecific hyaluronidase inhibitor in human blood.

Authors:  L W WATTENBERG; D GLICK
Journal:  Arch Biochem Biophys       Date:  1952-02       Impact factor: 4.013

5.  Mucolytic enzyme systems XVI. Factors influencing hyaluronidase inhibitor levels in serum, role of adrenal cortex.

Authors:  T A GOOD; R A GOOD; V C KELLEY; D GLICK
Journal:  Am J Physiol       Date:  1951-09

6.  Effects of cortisol released cutaneous protease upon the permeability of the micro-circulation.

Authors:  A W Lykke; D A Willoughby; J C Houck
Journal:  J Invest Dermatol       Date:  1967-04       Impact factor: 8.551

7.  Pepstatin, a new pepsin inhibitor produced by Actinomycetes.

Authors:  H Umezawa; T Aoyagi; H Morishima; M Matsuzaki; M Hamada
Journal:  J Antibiot (Tokyo)       Date:  1970-05       Impact factor: 2.649

8.  Isoelectric fractionation, analysis, and characterization of ampholytes in natural pH gradients. IV. Further studies on the resolving power in connection with separation of myoglobins.

Authors:  O Vesterberg; H Svensson
Journal:  Acta Chem Scand       Date:  1966

9.  Hyaluronidase-induced reductions in myocardial infarct size.

Authors:  D Maclean; M C Fishbein; P R Maroko; E Braunwald
Journal:  Science       Date:  1976-10-08       Impact factor: 47.728

  9 in total
  1 in total

1.  Inhibition of mast-cell degranulation by chemotactic peptides.

Authors:  J M Gleisner; C A Ramthun; J C Houck
Journal:  Inflammation       Date:  1981-03       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.